KK
CPRX

KLP Kapitalforvaltning’s Catalyst Pharmaceutical CPRX Stock Holding History

KLP Kapitalforvaltning’s Portfolio CPRX Stock Details CPRX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.82M Buy
73,500
+900
+1% +$21.4K 0.01% 751
2025
Q4 		$1.69M Buy
72,600
+33,500
+86% +$746K 0.01% 781
2025
Q3 		$770K Hold
39,100
– – ﹤0.01% 1176
2025
Q2 		$848K Buy
39,100
+2,100
+6% +$49.6K ﹤0.01% 1070
2025
Q1 		$897K Hold
37,000
– – ﹤0.01% 986
2024
Q4 		$772K Buy
+37,000
New +$795K ﹤0.01% 1110

Other funds holding CPRX

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
American Century Companies
American Century Companies Kansas City, Missouri $194B AUM 35% 1-Year Est. Return
DM
Deerfield Management New York $8.48B AUM 99.04% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM

KLP Kapitalforvaltning's CPRX Position: Q1 2026 in Review

KLP Kapitalforvaltning increased its Catalyst Pharmaceutical (CPRX) stake by 1.2% in Q1 2026, buying an estimated $21.4K and bringing the position to 73,500 shares worth $1.82M. The position accounts for 0.01% of the portfolio, ranked #751.

KLP Kapitalforvaltning first reported a position in CPRX in Q4 2024 and has held it in 6 quarters since. 380 funds tracked by Wall St. Rank hold CPRX as of Q1 2026.

  • KLP Kapitalforvaltning held 73,500 shares of Catalyst Pharmaceutical worth $1.82M as of Q1 2026.
  • KLP Kapitalforvaltning bought 900 Catalyst Pharmaceutical shares in Q1 2026, an estimated $21.4K.
  • Catalyst Pharmaceutical made up 0.01% of KLP Kapitalforvaltning's portfolio in Q1 2026, its #751 holding.
  • KLP Kapitalforvaltning first reported a position in Catalyst Pharmaceutical in Q4 2024 and has held it in 6 quarters since.
  • 380 funds tracked by Wall St. Rank held Catalyst Pharmaceutical as of Q1 2026.

Based on KLP Kapitalforvaltning's 13F filing for Q1 2026, filed 29 Apr 2026.